Rechberger JS - Search Results

1

The emerging role of nanotechnology in pursuit of successful drug delivery to H3K27M diffuse midline gliomas.

A Power E, Rechberger JS, Lu VM, Daniels DJ. A Power E, et al. Among authors: rechberger js. Nanomedicine (Lond). 2021 Jul;16(16):1343-1346. doi: 10.2217/nnm-2021-0067. Epub 2021 May 17. Nanomedicine (Lond). 2021. PMID: 33998840 No abstract available.

2

The 100 Most-Cited Articles About Convection-Enhanced Delivery to the Brain: A Bibliometric Analysis.

Lu VM, Rechberger JS, Himes BT, Daniels DJ. Lu VM, et al. Among authors: rechberger js. World Neurosurg. 2019 Sep;129:497-502.e6. doi: 10.1016/j.wneu.2019.05.179. Epub 2019 May 29. World Neurosurg. 2019. PMID: 31150865 Review.

3

Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.

Rechberger JS, Lu VM, Zhang L, Power EA, Daniels DJ. Rechberger JS, et al. Childs Nerv Syst. 2020 Jan;36(1):39-46. doi: 10.1007/s00381-019-04363-1. Epub 2019 Sep 6. Childs Nerv Syst. 2020. PMID: 31489454 Review.

4

Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.

Rechberger JS, Power EA, Lu VM, Zhang L, Sarkaria JN, Daniels DJ. Rechberger JS, et al. Neurosurg Focus. 2020 Jan 1;48(1):E2. doi: 10.3171/2019.10.FOCUS19703. Neurosurg Focus. 2020. PMID: 31896090 Free PMC article.

5

Convection-enhanced delivery for H3K27M diffuse midline glioma: how can we efficaciously modulate the blood-brain barrier?

Rechberger JS, Power EA, Daniels DJ. Rechberger JS, et al. Ther Deliv. 2021 Jun;12(6):419-422. doi: 10.4155/tde-2021-0026. Epub 2021 May 5. Ther Deliv. 2021. PMID: 33949200

6

Antibody-drug conjugates for H3K27M-mutant diffuse midline gliomas: prospects and challenges.

Rechberger JS, Power EA, Millesi E, Daniels DJ. Rechberger JS, et al. Ther Deliv. 2021 Aug;12(8):553-557. doi: 10.4155/tde-2021-0045. Epub 2021 Jul 21. Ther Deliv. 2021. PMID: 34286602 No abstract available.

7

Superselective intra-arterial cerebral infusion to improve brain tumor drug delivery.

Rechberger JS, Hayes CA, Thiele F, Power EA, Daniels DJ. Rechberger JS, et al. Ther Deliv. 2022 Jan;13(1):1-4. doi: 10.4155/tde-2021-0073. Epub 2021 Nov 2. Ther Deliv. 2022. PMID: 34726471

8

Status Quo and Trends of Intra-Arterial Therapy for Brain Tumors: A Bibliometric and Clinical Trials Analysis.

Rechberger JS, Thiele F, Daniels DJ. Rechberger JS, et al. Pharmaceutics. 2021 Nov 6;13(11):1885. doi: 10.3390/pharmaceutics13111885. Pharmaceutics. 2021. PMID: 34834300 Free PMC article. Review.

9

Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets.

Rechberger JS, Nesvick CL, Daniels DJ. Rechberger JS, et al. Expert Opin Ther Targets. 2022 Mar;26(3):187-192. doi: 10.1080/14728222.2022.2040017. Epub 2022 Feb 10. Expert Opin Ther Targets. 2022. PMID: 35142587 Free PMC article. No abstract available.

10

Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An update.

Power EA, Rechberger JS, Gupta S, Schwartz JD, Daniels DJ, Khatua S. Power EA, et al. Among authors: rechberger js. Adv Drug Deliv Rev. 2022 Jun;185:114303. doi: 10.1016/j.addr.2022.114303. Epub 2022 Apr 21. Adv Drug Deliv Rev. 2022. PMID: 35460714 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters